High testosterone levels in older men associated with greater risk of atrial fibrillation

FHS
May 2, 2024
10:06 am

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy older males.

GSK myeloma medicine improves survival in trial, another step in the drug’s revival

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a

December 9, 2024

Updated: Prime Medicine whittles down pipeline, signs gene editing deal with Bristol Myers

Prime Medicine is cutting its pipeline, but gaining a partner. The gene editing company, which once boasted a pipeline of 18 programs, is now focusing

October 1, 2024

Medtronic’s Renal Denervation System for Hypertension Splits FDA Panel

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.